These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26088929)

  • 1. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation.
    Gaillard C; Tokuyasu TA; Rosen G; Sotzen J; Vitaliano-Prunier A; Roy R; Passegué E; de Thé H; Figueroa ME; Kogan SC
    Haematologica; 2015 Aug; 100(8):1064-75. PubMed ID: 26088929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.
    Gaillard C; Surianarayanan S; Bentley T; Warr MR; Fitch B; Geng H; Passegué E; de Thé H; Kogan SC
    Blood Adv; 2018 Oct; 2(19):2462-2466. PubMed ID: 30266821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.
    Wojiski S; Guibal FC; Kindler T; Lee BH; Jesneck JL; Fabian A; Tenen DG; Gilliland DG
    Leukemia; 2009 Aug; 23(8):1462-71. PubMed ID: 19322209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting.
    Nasr R; de Thé H
    Int J Hematol; 2010 Jun; 91(5):742-7. PubMed ID: 20455087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
    Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
    Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
    Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J
    PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.
    Le Beau MM; Bitts S; Davis EM; Kogan SC
    Blood; 2002 Apr; 99(8):2985-91. PubMed ID: 11929790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL.
    di Masi A; Cilli D; Berardinelli F; Talarico A; Pallavicini I; Pennisi R; Leone S; Antoccia A; Noguera NI; Lo-Coco F; Ascenzi P; Minucci S; Nervi C
    Cell Death Dis; 2016 Jul; 7(7):e2308. PubMed ID: 27468685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.
    Matsushita H; Yahata T; Sheng Y; Nakamura Y; Muguruma Y; Matsuzawa H; Tanaka M; Hayashi H; Sato T; Damdinsuren A; Onizuka M; Ito M; Miyachi H; Pandolfi PP; Ando K
    PLoS One; 2014; 9(11):e111082. PubMed ID: 25369030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.
    Dos Santos GA; Kats L; Pandolfi PP
    J Exp Med; 2013 Dec; 210(13):2793-802. PubMed ID: 24344243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
    Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
    Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.
    Schoofs T; Rohde C; Hebestreit K; Klein HU; Göllner S; Schulze I; Lerdrup M; Dietrich N; Agrawal-Singh S; Witten A; Stoll M; Lengfelder E; Hofmann WK; Schlenke P; Büchner T; Hansen K; Berdel WE; Rosenbauer F; Dugas M; Müller-Tidow C
    Blood; 2013 Jan; 121(1):178-87. PubMed ID: 23152544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.
    Walter MJ; Park JS; Lau SK; Li X; Lane AA; Nagarajan R; Shannon WD; Ley TJ
    Mol Cell Biol; 2004 Dec; 24(24):10882-93. PubMed ID: 15572690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells.
    Katerndahl CDS; Rogers ORS; Day RB; Xu Z; Helton NM; Ramakrishnan SM; Miller CA; Ley TJ
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2317690121. PubMed ID: 38648485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice.
    Welch JS; Klco JM; Varghese N; Nagarajan R; Ley TJ
    Blood; 2011 Feb; 117(8):2460-8. PubMed ID: 21190992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.
    Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H
    Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.
    Le Beau MM; Davis EM; Patel B; Phan VT; Sohal J; Kogan SC
    Blood; 2003 Aug; 102(3):1072-4. PubMed ID: 12689927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.